Is PBM up or down today?
PBM is down 7.55% today, last at 2.94. This stock moved -7.55% versus the prior close.
PBM · PBM
PBM (PBM) is trading at 2.94, down 7.55% on the session. PBM sits at the 1% mark of its 52-week range, carries a 14-day RSI of 32, and trades below its 50-day average. Over the past month it is down 41.43%.
Leading the coverage: “What DOL’s Final PBM Rule Means for Rebates and Formularies - Pharmaceutical Commerce” (Google News, 7d ago). PBM is -18.56% since story.
PBM trades on a trailing P/E of 20.6 and is running 35.51% behind the S&P 500 over the same stretch.
Analyst firms are mostly reiterating — no strong directional shift lately.
PBM is down 7.55% today, last at 2.94. This stock moved -7.55% versus the prior close.
Leading the coverage: “What DOL’s Final PBM Rule Means for Rebates and Formularies - Pharmaceutical Commerce” (Google News, 7d ago). PBM is -18.56% since story. Dominant story: Evernorth earnings boosted by specialty business as PBM evolves - Modern Healthcare (1 source, bullish) RSI is 32 — leaning bearish Price below 50-day average — short-term weakness Social sentiment loads separately — see the Social tab.
Analyst firms are mostly reiterating — no strong directional shift lately.
Loaded: May 2026 – Nov 2026 (125 days) · Drag or scroll left for earlier dates
Evernorth earnings boosted by specialty business as PBM evolves - Modern Healthcare
[The Cigna Group Q3 2026 Earnings Call] Cigna Raises 2026 Adjusted EPS Guidance to at Least $30.60, but Says PBM Income Will Fall in 2027 - BigGo Finance
Cigna earnings ahead: Can specialty offset PBM pressures? - Investing.com
What DOL’s Final PBM Rule Means for Rebates and Formularies - Pharmaceutical Commerce
Pharmacy Law Lowdown: Defending Against PBM Inventory Audits - Drug Topics